Browsing: Greg Guenthner
Greg Guenthner, CMT, is the managing editor of The Rude Awakening. Greg is a member of the Market Technicians Association and holds the Chartered Market Technician designation.
Look, we ain’t gonna see $100 oil anytime soon. That's great news for businesses guzzling a lot of fuel. Operating costs are way down, which means higher profits. And higher stock prices. And yes, you can still find plenty of great opportunities to book profits as companies save money on fuel…
Nuclear power has been hammered since the Fukushima disaster in Japan four years ago. But as Greg Guenthner explains, nuclear power is making a comeback as countries around the world appreciate its great potential. He’ll also tell you exactly how to play this trend.
Just 44% of companies have beaten revenue estimates so far this earnings season. This is extremely low compared to past quarters during this five year bull market, and it's actually down at levels last seen during the final quarters of the Financial Crisis.
China is a buy on the dips market until the dips don't pop or we get the fireworks of a blow-off top. I'm not trying to oversimplify things--but buying the dips is the best way to handle a manic market like this one.
Traders have two options in this market: speed up...or slow down. And since I hope you have a life outside of watching a computer monitor between 9:30 and 4, I suggest you put your daytrading dreams on hold for a bit and hit the brakes.
Mickey D's has a new CEO to fix this mess. No matter. This dinosaur of a fast-food chain is on the road to ruin. Ronald is dying a slow, painful (possibly diabetes-related) death. And there's nothing anyone can do about it.
These attacks will continue. Russia and China are especially aggressive. And spending on cybersecurity will march higher as businesses and governments look to stay one step ahead of the bad guys.
So don't file those horns down just yet, biotech bulls. That bounce you're seeing right now could quickly propel this sector to new highs in a matter of days. Traders are already pouncing on some of the faster-moving biotech names.
The next time you're scared off from a $100 stock--don't be! There's no "reasonable amount of shares" you need to own in order to make money. Remember, if a stock can grow to $100 per share, what's to stop it from becoming a $500 stock? Or a $1,000 stock?
Markets around the world are beginning to break out in a big way. Some of the moves in international markets are so powerful right now they're catching most investors with their suit pants down.